Cochrane Abstracts
Moderately early (7‐14 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Moderately Early (7‐14 Days) Postnatal Corticosteroids for Preventing Chronic Lung Disease in Preterm Infants." Cochrane Abstracts, John Wiley & Sons, Inc, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433721/all/Moderately_early__7‐14_days__postnatal_corticosteroids_for_preventing_chronic_lung_disease_in_preterm_infants.
Moderately early (7‐14 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants. Cochrane Abstracts. John Wiley & Sons, Inc; 2026. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433721/all/Moderately_early__7‐14_days__postnatal_corticosteroids_for_preventing_chronic_lung_disease_in_preterm_infants. Accessed January 15, 2026.
Moderately early (7‐14 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants. (2026). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433721/all/Moderately_early__7‐14_days__postnatal_corticosteroids_for_preventing_chronic_lung_disease_in_preterm_infants
Moderately Early (7‐14 Days) Postnatal Corticosteroids for Preventing Chronic Lung Disease in Preterm Infants [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2026. [cited 2026 January 15]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433721/all/Moderately_early__7‐14_days__postnatal_corticosteroids_for_preventing_chronic_lung_disease_in_preterm_infants.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Moderately early (7‐14 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants
ID - 433721
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433721/all/Moderately_early__7‐14_days__postnatal_corticosteroids_for_preventing_chronic_lung_disease_in_preterm_infants
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
